These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19356768)

  • 21. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similarities between Brugada syndrome and ischemia-induced ST-segment elevation. Clinical correlation and synergy.
    Chinushi M; Furushima H; Tanabe Y; Washizuka T; Aizawaz Y
    J Electrocardiol; 2005 Oct; 38(4 Suppl):18-21. PubMed ID: 16226069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome.
    Mizumaki K; Fujiki A; Tsuneda T; Sakabe M; Nishida K; Sugao M; Inoue H
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):667-73. PubMed ID: 15175062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Mikouchi H; Nishizaki Y; Ohe T
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):870-6. PubMed ID: 15333077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report].
    Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of baroreflex stimulation using phenylephrine injection on ST segment elevation and ventricular arrhythmia-inducibility in Brugada syndrome patients.
    Probst V; Mabo P; Sacher F; Babuty D; Mansourati J; Le Marec H
    Europace; 2009 Mar; 11(3):382-4. PubMed ID: 19131343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transition of the ST segment from a J wave to a coved-type elevation before ventricular fibrillation induced by coronary vasospasm in the precordial leads.
    Inoue M; Matsubara T; Yasuda T; Miwa K; Kanaya H
    J Electrocardiol; 2010; 43(5):418-21. PubMed ID: 20667548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
    Chinushi M; Tagawa M; Izumi D; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):811-5. PubMed ID: 19545347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
    Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
    Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
    Nishii N; Nagase S; Morita H; Kusano KF; Namba T; Miura D; Miyaji K; Hiramatsu S; Tada T; Murakami M; Watanabe A; Banba K; Sakai Y; Nakamura K; Oka T; Ohe T
    Europace; 2010 Apr; 12(4):544-52. PubMed ID: 20083482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of a concealed type of Brugada syndrome with a J wave and mild ST-segment elevation in the inferolateral leads.
    Ueyama T; Shimizu A; Esato M; Kanemoto M; Kametani R; Sawa A; Suzuki S; Matsuzaki M
    J Electrocardiol; 2007 Jan; 40(1):39-42. PubMed ID: 17067625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early repolarization syndrome and Brugada syndrome: is there any linkage?
    Di Grande A; Tabita V; Lizzio MM; Giuffrida C; Bellanuova I; Lisi M; Le Moli C; Amico S
    Eur J Intern Med; 2008 Jun; 19(4):236-40. PubMed ID: 18471670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brugada syndrome, manifested by propafenone induced ST segment elevation.
    Aksay E; Okan T; Yanturali S
    Emerg Med J; 2005 Oct; 22(10):748-50. PubMed ID: 16189048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
    Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of quinidine in treatment of electrical storm in Brugada syndrome.
    Mok NS; Chan NY; Chiu AC
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):821-3. PubMed ID: 15189543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil.
    Tullo NG; Landau S; Goldman I; Coutinho N; Somberg J
    Acta Anaesthesiol Scand Suppl; 1993; 99():43-7. PubMed ID: 8480506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.